Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)
Sumatriptan Tablet
Product Images NDC 65862-147
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 65862-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)
Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))
Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))
This appears to be a label for Sumatriptan Tablets with instructions for usage, dosage information, and storage recommendations. The tablets contain 35 mg of Sumatriptan succinate USP. The label also includes the product code and information for the manufacturer, Aurobindo Pharma USA.*
Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))
This is a medication information sheet for Sumatriptan Tahlets, used in the treatment of migraine headaches. The sheet provides details such as the dosage, storage instructions, and manufacturer information. It further mentions that the usual dosage is printed on the package, and it is a prescription drug. The sheet also provides information for storing the medication temperature-wise and mentions the code of the medicine.*
Sumatriptan Fig6
Sumatriptan Fig7
This is a pharmaceutical product labelled "Rx only" with the ND number 65862-148-50 for Sumatriptan Tahlets, USP manufactured by Aurobindo. The package contains 36 tablets with each tablet containing 140 mg of Sumatriptan succinate USP equivalent to 10100 mg of sumatrptan. The recommended dosage and usage instructions can be found in the package insert. The tablets should be swallowed whole with water and not be split. They should be stored between 20° to 25% (68° to 77°F) with excursions permitted between 15° to 30° (59° to 85°F) at the USF Controlled Room Temperature. The product is distributed by Aurobindo Pharma, USA, Inc. with a manufacturing location in India.*
Sumatriptan Fig8
This text appears to be an instruction leaflet for Sumatriptan Tablets USP, used for treating migraines. It recommends taking the tablet orally with water but not breaking or crushing it. It advises not to store it in places with extreme temperatures or with other medications. The tablet contains 140 mg of sumatriptan succinate USP, equal to 100 mg of sumatriptan. The label also includes the drug's NDC number (65862-148-36) and the manufacturer's information (Aurobindo Pharma).*
Chemical Structure (Sumatriptan Str)
Not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
